Catalyst Wire Dossier Catalyst Wire Dossier

Liquid Certolizumab Pegol

certolizumab pegol · UCB Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Liquid Certolizumab Pegol, covering 2013-03-07 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis [Phase 3]

See pricing